从血液性恶性瘤的3期随机对照试验中排除患有功能障碍的患者
Danuta Kłosowska1, Michał Ordak2, Ewa Lech-Marańda3
1Department of Clinical Immunology, Medical University of Warsaw, Warsaw, Poland.
许多血液癌症药物的第三期临床试验将功能障碍患者排除在外. 这限制了对大量患者群体药物安全性和疗效的理解,需要对符合条件的标准进行审查.
科学领域:
- 血液性恶性瘤 血液性恶性瘤
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床试验的设计
背景情况:
- 第三期随机对照试验 (RCT) 对于血液恶性瘤中药物评估至关重要.
- 大约50%的患有这些癌症的患者患有一定程度的功能障碍.
- 从试验中排除功能障碍患者限制了概括性.
研究的目的:
- 在白血病,淋巴瘤和多发性髓瘤的第三阶段RCT中分析与功能障碍相关的排除标准.
- 确定与功能障碍患者排除相关的因素.
主要方法:
- 在clinicaltrials.gov (2009-2023) 上注册的554个第三期RCT的综合分析.
- 检查了特别提到功能障碍的排除标准,包括肌素清除率和血清肌素水平.
- 使用多变量分析来确定排除的预测因素.
主要成果:
- 超过66% (370/554) 的RCT包括功能障碍排除标准.
- 肌素清除/eGFR和血清肌素是最常见的排除指标.
- 白血病试验和商业资助的RCT显示,脏排除的几率更高.
结论:
- 显著的大多数第3期血液性恶性瘤RCT排除了患有功能障碍的患者.
- 这种排除可能会阻碍在大量患者群体中评估药物的疗效和安全性.
- 应考虑放宽资格标准,以包括功能障碍患者.
更多相关视频
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
相关概念视频
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
